Rang	Name	Position
1	Mr. Stephen Allen Hurly M.B.A., M.Sc.	CEO, President & Executive Director
2	Mr. Fred M. Powell CPA	Chief Financial Officer
3	Dr. Charles Q. Morris M.D., MBChB, MRCP (UK), Ph.D.	Chief Medical Officer
4	Ms. Oxana Polyakova Ph.D.	Chief Scientific Officer
5	Ms. Amy Garabedian J.D.	General Counsel & Corporate Secretary
6	Dr. Hans van der Vliet M.D., Ph.D.	Head of Innovation
7	Dr. Ton Adang Ph.D.	Chief Development Officer
8	Mr. Owen P. Hughes Jr.	Executive Director

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Redmile Group, LLC	7,89%	3,61 Mio. USD
2	BML Capital Management LLC	7,49%	3,43 Mio. USD
3	Sanofi	7,30%	3,34 Mio. USD
4	Merck & Co Inc	4,37%	2,00 Mio. USD
5	Bruce & Co Inc	1,98%	0,91 Mio. USD
6	Pathway Financial Advisors LLC	0,39%	0,18 Mio. USD
7	PNC Financial Services Group Inc	0,25%	0,11 Mio. USD
8	Citadel Advisors Llc	0,20%	0,09 Mio. USD
9	BNP Paribas Arbitrage, SA	0,18%	0,08 Mio. USD
10	Two Sigma Investments LLC	0,13%	0,06 Mio. USD
11	UBS Group AG	0,06%	0,03 Mio. USD
12	TWO SIGMA SECURITIES, LLC	0,05%	0,03 Mio. USD
13	Geode Capital Management, LLC	0,05%	0,03 Mio. USD
14	Morgan Stanley - Brokerage Accounts	0,04%	0,02 Mio. USD
15	TSFG, LLC	0,00%	0,00 Mio. USD
16	JONES FINANCIAL COMPANIES LLLP	0,00%	0,00 Mio. USD
17	SBI Securities Co Ltd	0,00%	0,00 Mio. USD
18	Millennium Management LLC	0,00%	0,00 Mio. USD
19	Atlantic Trust Group, LLC	0,00%	0,00 Mio. USD
20	Virtu Financial LLC	0,00%	0,00 Mio. USD